1-10 of 10
Xiaoyun Liao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer

Available to Purchase
Yohei Masugi, Reiko Nishihara, Tsuyoshi Hamada, Mingyang Song, Annacarolina da Silva, Keisuke Kosumi, Mancang Gu, Yan Shi, Wanwan Li, Li Liu, Daniel Nevo, Kentaro Inamura, Yin Cao, Xiaoyun Liao, Katsuhiko Nosho, Andrew T. Chan, Marios Giannakis, Adam J. Bass, F. Stephen Hodi, Gordon J. Freeman, Scott J. Rodig, Charles S. Fuchs, Zhi Rong Qian, Jonathan A. Nowak, Shuji Ogino
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (11): 1046–1055.
https://doi.org/10.1158/2326-6066.CIR-17-0122
Published: 31 October 2017
View articletitled, Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Open the PDF for Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Free
Jun Zhou, Kathleen M. Mahoney, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H. Butterfield, Matthias Piesche, Michael P. Manos, Lauren M. Eastman, Glenn Dranoff, Gordon J. Freeman, F. Stephen Hodi
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2017) 5 (6): 480–492.
https://doi.org/10.1158/2326-6066.CIR-16-0329
Published: 01 June 2017
View articletitled, Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Open the PDF for Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes

Available to Purchase
Xinqi Wu, Jingjing Li, Erin M. Connolly, Xiaoyun Liao, Jing Ouyang, Anita Giobbie-Hurder, Donald Lawrence, David McDermott, George Murphy, Jun Zhou, Matthias Piesche, Glenn Dranoff, Scott Rodig, Margaret Shipp, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (6): 446–454.
https://doi.org/10.1158/2326-6066.CIR-16-0385
Published: 01 June 2017
View articletitled, Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Open the PDF for Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy

Available to Purchase
Xinqi Wu, Anita Giobbie-Hurder, Xiaoyun Liao, Courtney Connelly, Erin M. Connolly, Jingjing Li, Michael P. Manos, Donald Lawrence, David McDermott, Mariano Severgnini, Jun Zhou, Evisa Gjini, Ana Lako, Mikel Lipschitz, Christine J. Pak, Sara Abdelrahman, Scott Rodig, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (1): 17–28.
https://doi.org/10.1158/2326-6066.CIR-16-0206
Published: 03 January 2017
View articletitled, Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
Open the PDF for Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy in another window
Includes: Supplementary data
Journal Articles

Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors

Available to Purchase
Mark M. Awad, Robert E. Jones, Hongye Liu, Patrick H. Lizotte, Elena V. Ivanova, Meghana Kulkarni, Grit S. Herter-Sprie, Xiaoyun Liao, Abigail A. Santos, Mark A. Bittinger, Lauren Keogh, Shohei Koyama, Christina Almonte, Jessie M. English, Julianne Barlow, William G. Richards, David A. Barbie, Adam J. Bass, Scott J. Rodig, F. Stephen Hodi, Kai W. Wucherpfennig, Pasi A. Jänne, Lynette M. Sholl, Peter S. Hammerman, Kwok-Kin Wong, Raphael Bueno
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (12): 1038–1048.
https://doi.org/10.1158/2326-6066.CIR-16-0171
Published: 30 November 2016
View articletitled, Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors
Open the PDF for Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors in another window
Includes: Supplementary data
Journal Articles

VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

Available to Purchase
Xinqi Wu, Anita Giobbie-Hurder, Xiaoyun Liao, Donald Lawrence, David McDermott, Jun Zhou, Scott Rodig, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (10): 858–868.
https://doi.org/10.1158/2326-6066.CIR-16-0084
Published: 02 October 2016
View articletitled, VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma
Open the PDF for VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma in another window
Includes: Supplementary data
Journal Articles

Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes

Available to Purchase
Vishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, Nicole G. Chau, Robert I. Haddad, Mariano Severgnini, Peter Hammerman, Adel El-Naggar, Gordon J. Freeman, F. Stephen Hodi, Scott J. Rodig, Glenn Dranoff, Jonathan D. Schoenfeld
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (8): 679–687.
https://doi.org/10.1158/2326-6066.CIR-16-0031
Published: 31 July 2016
View articletitled, Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes
Open the PDF for Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Available to Purchase
David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti H. Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van Den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (2): 124–135.
https://doi.org/10.1158/2326-6066.CIR-15-0151
Published: 01 February 2016
View articletitled, Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Open the PDF for Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model in another window
Includes: Supplementary data
Journal Articles

PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

Free
Kathleen M. Mahoney, Heather Sun, Xiaoyun Liao, Ping Hua, Marcella Callea, Edward A. Greenfield, F. Stephen Hodi, Arlene H. Sharpe, Sabina Signoretti, Scott J. Rodig, Gordon J. Freeman
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2015) 3 (12): 1308–1315.
https://doi.org/10.1158/2326-6066.CIR-15-0116
Published: 06 December 2015
View articletitled, PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
Open the PDF for PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma

Free
Sarah Derks, Katie S. Nason, Xiaoyun Liao, Matthew D. Stachler, Kevin X. Liu, Jie Bin Liu, Ewa Sicinska, Michael S. Goldberg, Gordon J. Freeman, Scott J. Rodig, Jon M. Davison, Adam J. Bass
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2015) 3 (10): 1123–1129.
https://doi.org/10.1158/2326-6066.CIR-15-0046
Published: 04 October 2015
View articletitled, Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
Open the PDF for Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma in another window
Includes: Supplementary data